Hellenic Bioscientific Association of the USA

Category Archives: Member’s Spotlight

  • Aristides A.N. Patrinos, Ph.D

    Member's Spotlight: Interview with Aristides A.N. Patrinos, Ph.D.

    Posted on January 1, 2016 by Hellenic Bioscientific Association in Member's Spotlight.

    Dr. Patrinos joined NYU-Poly from Synthetic Genomics Inc. (SGI), a privately held company founded in 2005 applying genomic-driven commercial solutions that address global energy and environmental challenges. At SGI he served as President and as Senior Vice President for Corporate Affairs. Prior to joining SGI, Dr. Patrinos was instrumental in advancing the scientific and policy framework underpinning key governmental energy and environmental initiatives while serving as associate director of the Office of Biological and Environmental Research in the U.S. Department of Energy’s Office of Science. Dr. Patrinos played a historic role in the Human Genome Project, the founding of the DOE Joint Genome Institute and the design and launch of the DOE’s Genomes to Life Program, a research program dedicated to developing technologies to use microbes for innovative solutions to energy and environmental challenges.

    Continue Reading...
    Comments Off on Interview with Aristides A.N. Patrinos, Ph.D.
  • Member's Spotlight: Interview with Dr. Konstantinos Drosatos, HBA-USA founder

    Posted on October 4, 2015 by Hellenic Bioscientific Association in Member's Spotlight.

    The HBA would like to kick off the new section of the site with the republishing of an interview of Dr. K. Drosatos who is a founding member of the HBA, has been with HBA since its inception and has been supporting the Association in all its steps. The interview was first published in the Greek-American publication “Cosmopolis” in December 2010 (Vol. 2, No. 1). Since then we did some edits to reflect the current achievements and direction of HBA. Dr. Drosatos is currently an Assistant Professor in Pharmacology & Center for Translational Medicine at Temple University. His research aims to elucidate the mechanisms that underlie sepsis-induced cardiac energy deprivation and coordinate with clinical scientists to propose potential treatments for improvement of heart function in septic patients. The findings of his studies can be extrapolated to other types of cardiac dysfunction and propose novel therapies for the treatment of heart failure (HF). In addition, we are exploring the cardiac metabolic profile and its contribution in the phenotype of other diseases, such as the Spinal Muscular Atrophy (SMA).

    Continue Reading...
    Comments Off on Interview with Dr. Konstantinos Drosatos, HBA-USA founder